An interventional study of Reparel Bioactive Sleeve and TED Stocking in Osteoarthritis (OA) of the Hip, sponsored by Reparel. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Reparel · Not applicable, Interventional, and Treatment
This randomized, prospective study compares the effectiveness of a novel bioactive garment (Reparel Leg Sleeve) versus standard TED compression stockings in reducing postoperative leg swelling, pain, and deep vein thrombosis (DVT) rates following total hip arthroplasty. The study aims to determine whether the bioactive garment improves patient comfort and recovery outcomes compared to traditional stockings.
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's planned enrollment of 50 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →This is the only study on the registry with Reparel as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants receive the Reparel Bioactive Sleeve on the operative leg and the Standard TED Stocking on the non-operative leg.
Device: Reparel Bioactive Sleeve
Participants receive the Reparel Bioactive Sleeve on the non-operative leg and the Standard TED Stocking on the operative leg.
Device: TED Stocking
A non-compressive, photobiomodulating sleeve worn on the leg to reduce postoperative pain and swelling.
Standard-of-care gradient compression stocking used after hip replacement.
Pain Score (VAS)
Pain will be measured using the Visual Analog Scale (VAS), a standard 0-10 numeric rating scale. Patients will report pain levels during routine postoperative follow-up visits or via validated questionnaires.
Time frame: Postoperative Weeks 2, 6, and 12
HOOS Jr. Score
The Hip Disability and Osteoarthritis Outcome Score, Junior (HOOS Jr.) evaluates hip function and patient-reported symptoms following total hip arthroplasty.
Time frame: Postoperative Weeks 6 and 12
VR-12 Score
The Veterans RAND 12-Item Health Survey (VR-12) evaluates patient-reported physical and mental health status.
Time frame: Postoperative Week 12
HSS Satisfaction Score
The Hospital for Special Surgery (HSS) Satisfaction Score assesses patient satisfaction following hip replacement surgery.
Time frame: Postoperative Week 12
Forgotten Joint Score
The Forgotten Joint Score measures the extent to which patients are aware of their hip joint during daily activities, reflecting functional recovery.
Time frame: Postoperative Week 12
Leg Swelling (Clinical Evaluation)
Leg swelling will be assessed during routine postoperative clinic visits through standard clinical evaluation, including circumferential measurement and visual assessment for edema.
Time frame: Postoperative Weeks 2, 6, and 12
Incidence of Deep Vein Thrombosis
Deep vein thrombosis (DVT) occurrence will be monitored through standard postoperative care, including clinical evaluation and diagnostic testing if symptoms suggest DVT.
Time frame: Up to 12 weeks after surgery
Postoperative Narcotic Use
Self-reported narcotic medication use will be documented through postoperative questionnaires to compare pain-management differences between intervention assignments.
Time frame: Collected at 2, 6, and 12 weeks after surgery
Study Questionnaire Responses
Patients will complete a study-specific questionnaire assessing comfort, usability, perceived swelling, and overall satisfaction with the leg garments.
Time frame: Weeks 2, 6, and 12 postoperatively
Documents are hosted by the registry — open the source record to download them.
Plan to share: Undecided
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.